Method and system for controlled infusion of therapeutic substances
First Claim
Patent Images
1. A method for administrating a substance to a subject, said method comprising the steps of:
- A) providing a system that comprises i) a pump, ii) a controller that is in communication with the pump and issues control signals to the pump, iii) a substance administering conduit for delivering the substance to the subject'"'"'s body, iv) a subject database containing information on at least one subject, v) a substance reference library, and vi) a user interface; and
B) creating a new infusion protocol or selecting an infusion protocol that is stored in the subject database and loading the infusion protocol into the controller;
C) querying the subject on whether the subject is experiencing an adverse reaction and enabling the subject to respond to the query via the user interface;
D) determining whether the subject'"'"'s response to the query indicates the subject is experiencing an adverse reaction stored in the substance reference library in association with the substance; and
E) comparing the infusion protocol loaded into the controller with infusion protocol limits stored in the subject database and;
i) when a parameter of the infusion protocol is outside of the protocol limits stored in the subject database, taking at least one remedial action selected from the group consisting of;
a) preventing execution of the infusion protocol, b) notifying the operator that the protocol loaded into the controller is outside of the subject'"'"'s limits and c) recording a record of the event in a history database,ii) when the subject'"'"'s response to the query indicates the subject is experiencing the adverse reaction stored in the substance reference library in association with the substance, the controller automatically causes the pump to stop or modify the rate of infusion, andiii) when no parameter of the infusion protocol is outside of the protocol limits stored in the subject database, causing the pump to administer the substance through the conduit and into the subject'"'"'s body in accordance with the infusion protocol.
3 Assignments
0 Petitions
Accused Products
Abstract
Programmable infusion systems and method for controlled infusion of diagnostic or therapeutic substances (e.g., drugs, biologics, fluids, cell preparations, etc.) into the bodies of human or animal subjects.
169 Citations
41 Claims
-
1. A method for administrating a substance to a subject, said method comprising the steps of:
-
A) providing a system that comprises i) a pump, ii) a controller that is in communication with the pump and issues control signals to the pump, iii) a substance administering conduit for delivering the substance to the subject'"'"'s body, iv) a subject database containing information on at least one subject, v) a substance reference library, and vi) a user interface; and B) creating a new infusion protocol or selecting an infusion protocol that is stored in the subject database and loading the infusion protocol into the controller; C) querying the subject on whether the subject is experiencing an adverse reaction and enabling the subject to respond to the query via the user interface; D) determining whether the subject'"'"'s response to the query indicates the subject is experiencing an adverse reaction stored in the substance reference library in association with the substance; and E) comparing the infusion protocol loaded into the controller with infusion protocol limits stored in the subject database and; i) when a parameter of the infusion protocol is outside of the protocol limits stored in the subject database, taking at least one remedial action selected from the group consisting of;
a) preventing execution of the infusion protocol, b) notifying the operator that the protocol loaded into the controller is outside of the subject'"'"'s limits and c) recording a record of the event in a history database,ii) when the subject'"'"'s response to the query indicates the subject is experiencing the adverse reaction stored in the substance reference library in association with the substance, the controller automatically causes the pump to stop or modify the rate of infusion, and iii) when no parameter of the infusion protocol is outside of the protocol limits stored in the subject database, causing the pump to administer the substance through the conduit and into the subject'"'"'s body in accordance with the infusion protocol. - View Dependent Claims (2, 3, 4, 5, 6, 7, 10, 11, 12, 13, 14, 15, 16, 17, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)
-
-
8. A method 1 further comprising the step of:
establishing a therapy-type protocol database with at least one infusion protocol based on therapy type. - View Dependent Claims (9)
-
18. A method for administrating a substance to a subject, said method comprising the steps of:
-
A) providing a system that comprises i) a pump, ii) a controller that is in communication with the pump and issues control signals to the pump, iii) a substance administering conduit for delivering the substance to the subject'"'"'s body, iv) a subject database containing information on at least one subject, v) a substance reference library, and v) vi) a user interface; B) creating a new infusion protocol or selecting an infusion protocol that is stored in the subject database and loading the infusion protocol into the controller; C) querying the subject on whether the subject is experiencing an adverse reaction and enabling the subject to respond to the query via the user interface; D) determining whether the subject'"'"'s response to the query indicates the subject is experiencing an adverse reaction stored in the substance reference library in association with the substance; and E) when the patient is suffering a mild adverse reaction stored in the reference library; (i) the controller automatically causing the pump to stop the infusion and provide a user a mild adverse reaction advisory, (ii) providing the user an option of initiating a new measurement of the monitored physiological variable(s), (iii) when the user elects to proceed with the new measurement of the physiological variable(s); (a) proceeding with the new measurement, and (b) providing the user an option of having the newly measured physiological variables analyzed, (iv) when the user does not elect to have the newly measured physiological variable(s) analyzed or does not proceed with the new measurement of the physiological variable(s), suggesting a lower substance administration rate or enabling the user to enter a lower substance administration rate, and (v) when the user does not accept the suggested lower infusion rate or does not enter the lower infusion rate, enabling the user to override the mild adverse reaction advisory and resuming the substance administration.
-
-
19. A method for administrating a substance to a subject, said method comprising the steps of:
-
A) providing a system that comprises i) a pump, ii) a controller that is in communication with the pump and issues control signals to the pump, iii) a substance administering conduit for delivering the substance to the subject'"'"'s body, iv) a subject database containing information on at least one subject, v) a substance reference library, and v) vi) a user interface; B) creating a new infusion protocol or selecting an infusion protocol that is stored in the subject database and loading the infusion protocol into the controller; C) querying the subject on whether the subject is experiencing an adverse reaction and enabling the subject to respond to the query via the user interface; D) determining whether the subject'"'"'s response to the query indicates the subject is experiencing an adverse reaction stored in the substance reference library in association with the substance; and E) when the patient is suffering a severe adverse reaction stored in the reference library; (a) the controller automatically causing the pump to stop the infusion and provide a user a severe adverse reaction advisory, (b) providing the user an option of initiating a new measurement of the monitored physiological variable(s), (c) when the user elects to proceed with the new measurement of the physiological variable(s); (i) proceeding with the new measurement, and (ii) providing the user an option of having the newly measured physiological variables analyzed, and (d) when the user does not elect to have the newly measured physiological variable(s) analyzed or does not proceed with the new measurement of the physiological variable(s), terminating the substance administration.
-
Specification